Vera Therapeutics (VERA) Other Operating Expenses (2021 - 2022)
Vera Therapeutics (VERA) reported Other Operating Expenses of $16.0 million for Q3 2022, up 492.94% quarter-over-quarter from $2.7 million in Q2 2021.
Vera Therapeutics (VERA) Other Operating Expenses (2021 - 2022) Analysis & Trends
Vera Therapeutics has reported Other Operating Expenses for 2 years, with the latest figure at $16.0 million in Q3 2022.
- For the quarter ending Q3 2022, Other Operating Expenses changed N/A year-over-year to $16.0 million; the trailing twelve-month figure through Jun 2023 stood at $16.0 million (changed N/A YoY), and the FY2021 full-year result was $2.7 million, changed N/A from the prior year.
- Other Operating Expenses for Q3 2022 stood at $16.0 million, up from $2.7 million in the prior quarter.
- The five-year high for Other Operating Expenses was $16.0 million in Q3 2022, with the low at $2.7 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vera Therapeutics | 2.51 Bn | 1.91 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 15.96 Mn |
| Jun 30, 2021 | 2.69 Mn |